Lack of correlation between three commercial platforms for the evaluation of human immunodeficiency virus type 1 (HIV-1) viral load at the clinically critical lower limit of quantification
- 31 December 2010
- journal article
- research article
- Published by Elsevier BV in Journal of Clinical Virology
- Vol. 49 (4), 249-253
- https://doi.org/10.1016/j.jcv.2010.08.016
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Impact of Discrepancies between the Abbott RealTime and Cobas TaqMan Assays for Quantification of Human Immunodeficiency Virus Type 1 Group M Non-B SubtypesJournal of Clinical Microbiology, 2009
- Increased Reporting of Detectable Plasma HIV-1 RNA Levels at the Critical Threshold of 50 Copies per Milliliter With the Taqman Assay in Comparison to the Amplicor AssayJAIDS Journal of Acquired Immune Deficiency Syndromes, 2009
- Human Immunodeficiency Virus Type 1 (HIV-1) Plasma Load Discrepancies between the Roche COBAS AMPLICOR HIV-1 MONITOR Version 1.5 and the Roche COBAS AmpliPrep/COBAS TaqMan HIV-1 AssaysJournal of Clinical Microbiology, 2007
- Multicenter evaluation of the NucliSens EasyQ HIV-1 v1.1 assay for the quantitative detection of HIV-1 RNA in plasmaJournal of Virological Methods, 2005
- The use of plasma HIV RNA as a study endpoint in efficacy trials of antiretroviral drugsAIDS, 1999
- Suppression of plasma viral load below 20 copies/ml is required to achieve a long-term response to therapyAIDS, 1998
- Use of Changes in Plasma Levels of Human Immunodeficiency Virus Type 1 RNA to Assess the Clinical Benefit of Antiretroviral TherapyThe Journal of Infectious Diseases, 1998
- Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral TherapyNew England Journal of Medicine, 1997
- A Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or LessNew England Journal of Medicine, 1997
- Decay characteristics of HIV-1-infected compartments during combination therapyNature, 1997